R Pg Family Wealth Advisory, LLC Biogen Inc. Transaction History

R Pg Family Wealth Advisory, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $28,490 - $45,618	-110 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $54,812 - $82,506	-232 Reduced 67.84%	110 $26,000
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $19,399 - $25,691	-75 Reduced 17.99%	342 $91,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $87,716 - $96,688	-400 Reduced 48.96%	417 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $3,250 - $5,084	15 Added 1.87%	817 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $83,550 - $105,825	300 Added 59.76%	802 $241,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $116,523 - $152,380	-397 Reduced 44.16%	502 $0
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $157,087 - $187,215	610 Added 211.07%	899 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $51,245 - $72,478	197 Added 214.13%	289 $0
Q3 2017 Nov 08, 2017	SELL	$281.15 - $329.69 $19,680 - $23,078	-70 Reduced 43.21%	92 $0
Q2 2017 Aug 14, 2017	BUY	N/A	162	162 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.